Introduction Subanesthetic dose of ketamine was repeatedly shown to improve depressive symptoms with a short latency of 24 hours. Objective We aimed to test if clinical time course of improvement is indeed mirrored by increased glutamine/glutamate ratio and if such effects would show a regional and temporal specificity in two anatomically and functionally distinct subdivisions of ACC. Method We used a glutamine sensitive magnetic resonance spectroscopy protocol at 7 Tesla to compare the longitudinal changes of glutamine/glutamate after 1 hour and 24 hours in pregenual ACC (pgACC, Figure 1A) and anterior mid-cingulate cortex (aMCC, Figure 1B) in 59 healthy controls which underwent a double-blind, placebo-controlled ketamine infusion. Result ...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Background Ketamine-induced antidepressant effect has been reported in animal and human studies. The...
The glutamatergic modulator ketamine rapidly reduces depressive symptoms in individuals with treatme...
Introduction: Increasing preclinical and clinical evidence underscores the role of glutamate in the ...
Background: Ketamine is a potent NMDA receptor antagonist with rapid antidepressant properties at su...
Objective Using proton magnetic resonance spectroscopy (1H-MRS) an increase in glutamatergic metabol...
Background: Using proton magnetic resonance spectroscopy (1H-MRS) an increase in glutamatergic metab...
Introduction: Converging evidence suggests that ketamine elicits antidepressant effects via enhance...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Sub-anesthetic ketamine elicits rapid antidepressant response in patients via modulation of glutamat...
Background / Purpose: Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidep...
Ketamine is a powerful glutamatergic long-lasting antidepressant, efficient in intractable major dep...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties, th...
Objective Based on the growing evidence for imbalance with regard to glutamatergic (Glu) neurotransm...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Background Ketamine-induced antidepressant effect has been reported in animal and human studies. The...
The glutamatergic modulator ketamine rapidly reduces depressive symptoms in individuals with treatme...
Introduction: Increasing preclinical and clinical evidence underscores the role of glutamate in the ...
Background: Ketamine is a potent NMDA receptor antagonist with rapid antidepressant properties at su...
Objective Using proton magnetic resonance spectroscopy (1H-MRS) an increase in glutamatergic metabol...
Background: Using proton magnetic resonance spectroscopy (1H-MRS) an increase in glutamatergic metab...
Introduction: Converging evidence suggests that ketamine elicits antidepressant effects via enhance...
Following the discovery of the antidepressant properties of ketamine, there has been a recent resurg...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Sub-anesthetic ketamine elicits rapid antidepressant response in patients via modulation of glutamat...
Background / Purpose: Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidep...
Ketamine is a powerful glutamatergic long-lasting antidepressant, efficient in intractable major dep...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties, th...
Objective Based on the growing evidence for imbalance with regard to glutamatergic (Glu) neurotransm...
Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidepressant properties at ...
Background Ketamine-induced antidepressant effect has been reported in animal and human studies. The...
The glutamatergic modulator ketamine rapidly reduces depressive symptoms in individuals with treatme...